Johnson & Johnson Announces Five Initiatives to Help Find the ‘Missing Millions’ of Undiagnosed People Living with Tuberculosis

NEW BRUNSWICK, N.J., 24 March 2021 – In recognition of World Tuberculosis (TB) Day, Johnson & Johnson today announced a series of new commitments and collaborations in support of global efforts to find and deliver care to the millions of adults and children living with TB who have not yet been diagnosed. Successfully identifying these people, especially those living with multidrug-resistant TB (MDR-TB), remains one of the most significant obstacles in achieving the United Nations (UN) Sustainable Development Goal of ending TB by 2030. These initiatives—together with the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund); U.S. Agency for International Development (USAID); PATH; Aquity Innovations and several private sector organizations—will help to identify more people living with TB and help enable them to access care. Three of the initiatives will focus specifically on improving pediatric diagnosis and treatment, while two will accelerate care for adults. "While the world has made strides in recent years against TB, COVID-19 threatens this hard-won progress as more people living with TB are now going undiagnosed,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson. "Johnson & Johnson is committed to supporting urgently-needed efforts to help identify the ‘missing millions’ of undiagnosed individuals with TB and connect them with care to help put the world back on tra...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news